CARDIZEM LA (diltiazem hydrochloride) Bausch Patent: 6,923,984 Expiration: Feb 25, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
The post Dr…
Drug Patent Expirations for the Week of February 21, 2021 Read Post »
Annual Drug Patent Expirations for BRIVIACT Briviact is a drug marketed by Ucb Inc and is included in three NDAs. It is available from one supplier. There are four patents…
The post New patent expiration for Ucb Inc drug BRIVIACT appeared first on Drug…
Annual Drug Patent Expirations for CLARINEX-D+12+HOUR Clarinex-d 12 Hour is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There…
The post New patent expiration for Merck Sharp drug CLARINEX-D 12 HOU…
New patent expiration for Merck Sharp drug CLARINEX-D 12 HOUR Read Post »
CLARINEX-D 12 HOUR (desloratadine; pseudoephedrine sulfate) Merck sharp dohme Patent: 6,709,676 Expiration: Feb 18, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of February 14, 2021 Read Post »
Annual Drug Patent Expirations for ENJUVIA Enjuvia is a drug marketed by Aspen and is included in one NDA. There are two patents protecting this drug. This drug has seventeen…
The post New patent expiration for ASPEN drug ENJUVIA appeared first on Drug…
Annual Drug Patent Expirations for CRIXIVAN Crixivan is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from one supplier. There is one…
The post New patent expiration for Merck Sharp drug CRIXIVAN appeared first on Dru…
New patent expiration for Merck Sharp drug CRIXIVAN Read Post »
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of February 7, 2021 Read Post »
ENJUVIA (estrogens, conjugated synthetic b) Aspen Patent: 6,855,703 Expiration: Feb 12, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirations…
Drug Patent Expirations for the Week of February 7, 2021 Read Post »
Annual Drug Patent Expirations for CRESTOR Crestor is a drug marketed by IPR and is included in one NDA. It is available from four suppliers. There are two patents protecting…
The post New patent expiration for IPR drug CRESTOR appeared first on DrugPa…
Annual Drug Patent Expirations for AURYXIA Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fifteen patents…
The post New patent expiration for Keryx Biopharms drug AURYXIA appeared …
New patent expiration for Keryx Biopharms drug AURYXIA Read Post »